MedPath

Evaluation of use of human donor skin grafts in treating burn wounds.

Not Applicable
Conditions
Health Condition 1: T300- Burn of unspecified body region, unspecified degree
Registration Number
CTRI/2021/01/030558
Lead Sponsor
Dr Annappa Kudva
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with Partial thickness burns undergoing tangential excision (Debridement) and allografting of burn wounds after hemodynamic stability in the department of Plastic Surgery

Exclusion Criteria

1)Patients on Medications negatively affecting wound healing such as Corticosteroids, Chemotherapeutic agents.

2)Age > 75years, <1 year

3)Chemical induced Burns, Radiation Burns, Cold Burns, Immunocompromised patients and patient with collagen disorders.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of human skin allograft in the wound healing of partial thickness burn wounds as a definitive dressing. <br/ ><br> <br/ ><br>Wound is considered healing based on either of the following criteria <br/ ><br>1.Peeling of allograft with evidence of epithelization of surface underneath. <br/ ><br>2.Grafted area appears dry or the secretions from the grafted area are decreased when inspected on POD 4, POD 10, POD 15 and POD 21. <br/ ><br>Timepoint: Upto POD 21
Secondary Outcome Measures
NameTimeMethod
Allograft rejection and scarTimepoint: Upto 3 months after allograft application
© Copyright 2025. All Rights Reserved by MedPath